EN PL
REVIEW ARTICLE
Advances in the diagnosis and treatment of rhinogenic headache and facial pain – a narrative review
 
More details
Hide details
1
Katedra Medycyny Rodzinnej i Chorób Zakaźnych, Uniwersytet Warmińsko-Mazursk, Polska
 
 
Submission date: 2026-04-21
 
 
Final revision date: 2026-06-13
 
 
Acceptance date: 2026-06-21
 
 
Publication date: 2026-06-28
 
 
Corresponding author
Marcin Straburzyński   

Katedra Medycyny Rodzinnej i Chorób Zakaźnych, Uniwersytet Warmińsko-Mazursk, al. Warszawska 30, 10-082, Olsztyn, Polska
 
 
RhinoScope 2026;1(2):12-17
 
KEYWORDS
TOPICS
ABSTRACT
This narrative review addresses the diagnosis and treatment of headaches and facial pain of rhinogenic origin. The majority of cases misdiagnosed as "sinus headache" actually meet the diagnostic criteria for mi-graine or non-rhinogenic facial pain syndromes, such as idiopathic midfacial pain (IMFP). The overlap be-tween migraine and sinusitis phenotypes stems from the activation of the trigeminal-autonomic reflex and the release of neuropeptides, leading to the development of nasal cranial autonomic symptoms. Emerging evidence highlights the value of specific findings in differentiating between rhinogenic and non-rhinogenic headache/facial pain: rhinosinusitis is indicated by discolored nasal discharge, pronounced inflammatory changes on nasal endoscopy and paranasal sinus CT scans, and a prolonged symptom course. Conversely, primary headache and facial pain disorders are suggested by a relatively short attack duration (lasting up to 72 hours) and the presence of vegetative symptoms (hypersensitivity to light, sound, and smells; nausea). It is important to note that surgical interventions are not justified in cases of neurogenic headache and facial pain. Initial screening tools, such as the Sinus Headache Screener (SHS) questionnaire, along with proposed modifications to ICHD and ICOP criteria, facilitate improved differential diagnosis.
REFERENCES (15)
1.
Eross E, Dodick D, Eross M. The Sinus, Allergy and Migraine Study (SAMS). Headache. 2007;47(2):213–224. doi:10.1111/j.1526-4610.2006.00688.x.
 
2.
Straburzyński M, Gryglas-Dworak A, Nowaczewska M, Brożek-Mądry E, Martelletti P. Etiology of ‘Sinus Headache’—Moving the Focus from Rhinology to Neurology. A Systematic Review. Brain Sci. 2021;11(1):79. doi:10.3390/brainsci11010079.
 
3.
Cady RK, Dodick DW, Levine HL, Schreiber CP, Eross EJ, Setzen M, et al. Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatment. Mayo Clin Proc. 2005;80(7):908–916. doi:10.4065/80.7.908.
 
4.
Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1–464. doi:10.4193/Rhin20.600.
 
5.
Al-Hashel JY, Ahmed SF, Alroughani R, Goadsby PJ. Migraine misdiagnosis as a sinusitis, a delay that can last for many years. J Headache Pain. 2013;14:97. doi:10.1186/1129-2377-14-97.
 
6.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. doi:10.1177/0333102417738202.
 
7.
Karsan N, Nagaraj K, Goadsby PJ. Cranial autonomic symptoms: prevalence, phenotype and laterality in migraine and two potentially new symptoms. J Headache Pain. 2022;23(1):18. doi:10.1186/s10194-022-01389-w.
 
8.
Straburzyński M, Waliszewska-Prosół M, Nowaczewska M, Czapinska-Ciepiela EK, Gryglas-Dworak A, Budrewicz S. Prevalence of cranial autonomic symptoms in frequent episodic tension-type headache: a post hoc analysis of the cross-sectional Migraine in Poland study. Dent Med Probl. 2024;61(4):489–493. doi:10.17219/dmp/175611.
 
9.
Bellamy JL, Cady RK, Durham PL. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Headache. 2006;46(1):24–33. doi:10.1111/j.1526-4610.2006.00294.x.
 
10.
Straburzynski M, Nowaczewska M, Czapinska-Ciepiela EK, Gryglas-Dworak A, Budrewicz S, Waliszewska-Prosół M. Sinonasal symptoms in migraine without aura: results from the cross-sectional ‘Migraine in Poland’ study. Front Neurol. 2023;14:1321261. doi:10.3389/fneur.2023.1321261.
 
11.
Coles T, Mkumba LS, Wright L, Godley FA, Collins TA, Jang DW. Development of the Sinus Headache Screener to identify patients with non-rhinogenic facial pain compared with chronic rhinosinusitis in rhinology clinics. J Patient Rep Outcomes. 2025;9(1):130. doi:10.1186/s41687-025-00956-4.
 
12.
Straburzyński M, Agius AM, Hopkins C, Luong AU, De Corso E, May A, et al. Proposed changes to current definitions of ICHD-3 regarding headache and facial pain attributed to the disorder of the nose or paranasal sinuses. Cephalalgia. 2026;46(4):3331024261439265. doi:10.1177/03331024261439265.
 
13.
Orlandi RR, Kingdom TT, Hwang PH, Smith TL, Alt JA, Baroody FM, et al. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol. 2016;6(Suppl 1):S22–S209. doi:10.1002/alr.21695.
 
14.
Jones NS. Midfacial segment pain: implications for rhinitis and sinusitis. Curr Allergy Asthma Rep. 2004;4(3):187–192. doi:10.1007/s11882-004-0025-1.
 
15.
Straburzyński M, Bahn S, May A. Phenotype of midfacial pain in 12 new cases - A multidisciplinary idiopathic facial pain syndrome. Headache. 2026;66(1):230–238. doi:10.1111/head.15072.
 
ISSN:3072-5992
Journals System - logo
Scroll to top